Výsledky vyhledávání - "M. Kastrisiou"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

P-181 Role of detection and quantification of plasma ctDNA RAS mutations by BEAMing digital PCR in patients with locally advanced and metastatic pancreatic cancer

Autor: M. Kastrisiou, Anna Goussia, Georgios Pentheroudakis, Angeliki Magklara, K. Gkrepi, C. Tzallas, A. Kougioumtzi, A. Christopoulou, S. Gkoura

Publikováno v: Annals of Oncology. 31:S149

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a28895d6bdcf8e6bce60a3cde36d72da
https://doi.org/10.1016/j.annonc.2020.04.263

Zobrazit plný text záznamu

P-264 Clinical validation of next-generation sequencing as a liquid biopsy for the monitoring of patients with metastatic colorectal cancer

Autor: M. Kastrisiou, A. Batistatou, E. Tselikou, C. Tzallas, Eirini Papadopoulou, Georgios Zarkavelis, A. Mantziou, Angeliki Magklara, Georgios Pentheroudakis, G. Nasioulas

Publikováno v: Annals of Oncology. 31:S176

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d65f004ac2a5a5cdecaa4714764312e8
https://doi.org/10.1016/j.annonc.2020.04.346

Zobrazit plný text záznamu

Clonal evolution of colorectal cancer in a patient with serially resected metastases and liquid biopsies: a case report and discussion of the literature

Autor: Anna Goussia, Eleni Panopoulou, George Pentheroudakis, Eirini Papadopoulou, M. Kastrisiou, George Zarkavelis, Christina Tsaousi, George Nasioulas, Eleftherios Kampletsas

Publikováno v: ESMO Open

Background Metastatic colorectal cancer represents a striking example of clonal heterogeneity and tumour evolution, which generates acquired resistance to therapy. Once hard to perform, the study of clonal heterogeneity is now significantly aided by

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03689a404dca87437eaeb02b5bab4d69
http://europepmc.org/articles/PMC6012565

Zobrazit plný text záznamu

Nivolumab-induced hypothyroidism and selective pituitary insufficiency in a patient with lung adenocarcinoma: a case report and review of the literature

Autor: Dimitrios Petrakis, Evangelos Ntouvelis, Aristides Kefas, Amalia Vassou, George Pentheroudakis, M. Kastrisiou, Fereniki-Lida Kostadima, Alexandra Papadaki, George Zarkavelis, Nikos Kapodistrias

Publikováno v: ESMO Open

Immune checkpoint blockade including programmed cell death 1 pathway inhibition with agents such as nivolumab is gaining ground in a wide array of malignancies, so far demonstrating significantly improved survival rates even in metastatic, often mult

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98bbb9c71666438ce0eb5c9cdc7cb128
http://europepmc.org/articles/PMC5640091

Zobrazit plný text záznamu

Customisation of therapeutic strategy in metastatic colorectal cancer by use of liquid biopsies: Updated results of an observational study

Autor: M. Kastrisiou, G. Nasioulas, C. Tzallas, Georgios Pentheroudakis, Angeliki Magklara, Emmanouil Saloustros, Anastasia Kougioumtzi, Athanasios Kotsakis, Anna Batistatou, Eirini Papadopoulou, Georgios Zarkavelis

Publikováno v: Annals of Oncology. 30:vii13

Background Metastatic colorectal cancer (mCRC) affects 20% of patients diagnosed with colorectal malignancy and is a major cause of cancer-related death worldwide. Epidermal growth factor receptor (EGFR) blockade with monoclonal antibodies, in combin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9bc3a2e72d9fb58ab8d6848ea58c1eed
https://doi.org/10.1093/annonc/mdz413.046

Zobrazit plný text záznamu

Plasma ctDNA RAS mutation analysis by digital polymerase chain reaction in patients with inoperable pancreatic cancer

Autor: C. Tzallas, Anastasia Kougioumtzi, Anna Goussia, Georgios Pentheroudakis, M. Kastrisiou, K. Gkrepi, Angeliki Magklara, S. Gkoura

Publikováno v: Annals of Oncology. 30:vii12

Background Pancreatic ductal adenocarcinoma (PDAC) is associated with poor prognosis and high mortality worldwide. Despite the emergence of new therapeutic approaches for the treatment of inoperable PDAC, reliable prognostic/predictive biomarkers are

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e1280d87b23408552c6c2aff20e9ee68
https://doi.org/10.1093/annonc/mdz413.042

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání